0001437749-22-012833.txt : 20220517
0001437749-22-012833.hdr.sgml : 20220517
20220517171124
ACCESSION NUMBER: 0001437749-22-012833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220515
FILED AS OF DATE: 20220517
DATE AS OF CHANGE: 20220517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Brian F.
CENTRAL INDEX KEY: 0000940454
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 22935733
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN BRIAN F
DATE OF NAME CHANGE: 19950307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-05-15
0001603454
Celcuity Inc.
CELC
0000940454
Sullivan Brian F.
16305 36TH AVENUE N.
SUITE 100
MINNEAPOLIS
MN
55446
1
1
1
Chief Executive Officer
Common Stock
2755774
D
Common Stock (right to buy)
5.75
2022-05-15
4
P
0
260869
0
A
Common Stock
260869
260869
D
Warrants (right to buy)
80.50
2022-05-15
4
P
0
10434
0
A
Series A Preferred Stock
10434
10434
D
Stock Option (right to buy)
8.4000
2027-05-17
Common Stock
21500
21500
D
Stock Option (right to buy)
9.5000
2027-09-19
Common Stock
8220
8220
D
Stock Option (right to buy)
26.0000
2028-08-13
Common Stock
3769
3769
D
Stock Option (right to buy)
25.7700
2028-10-17
Common Stock
14675
14675
D
Stock Option (right to buy)
19.7200
2029-08-12
Common Stock
50000
50000
D
Stock Option (right to buy)
19.7200
2029-08-12
Common Stock
4985
4985
D
Stock Option (right to buy)
5.9000
2030-08-12
Common Stock
20000
20000
D
Stock Option (right to buy)
5.9000
2021-09-19
2030-08-12
Common Stock
17281
17281
D
Stock Option (right to buy)
10.3500
2030-12-28
Common Stock
11081
11081
D
Stock Option (right to buy)
14.8400
2031-02-02
Common Stock
12859
12859
D
Stock Option (right to buy)
15.9200
2031-03-18
Common Stock
11889
11889
D
Stock Option (right to buy)
27.9400
2031-04-12
Common Stock
13509
13509
D
Stock Option (right to buy)
20.0400
2022-08-11
2031-08-11
Common Stock
17000
17000
D
Stock Option (right to buy)
20.0400
2031-08-11
Common Stock
20000
20000
D
Stock Option (right to buy)
17.1900
2031-10-27
Common Stock
6569
6569
D
Represents the right to acquire the security pursuant to a securities purchase agreement entered into with the Company on May 15, 2022.
Fully vested.
3,668 shares vest on 10/17/19; the remaining 11,007 shares vest 1/36th per month thereafter.
12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter.
5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter.
2,770 shares vest on 12/29/21; the remaining 8,311 shares vest 1/36th per month thereafter.
3,214 shares vest on 2/2/22; the remaining 9,645 shares vest 1/36th per month thereafter.
2,972 shares vest on 3/18/22; the remaining 8,917 shares vest 1/36th per month thereafter.
3,377 shares vest on 4/12/22; the remaining 10,132 shares vest 1/36th per month thereafter.
5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter.
1,642 shares vest on 10/27/22; the remaining 4,927 shares vest 1/36th per month thereafter.
/s/ Eric O. Madson as attorney-in-fact for Brian F. Sullivan pursuant to Power of Attorney previously filed.
2022-05-17